Myc is a well-known transcription factor with important roles in cell cycle, apoptosis, and cellular transformation. Long noncoding RNAs (lncRNAs) have recently emerged as an important class of regulatory RNAs. Here, we show that lncRNAs are a main component of the Myc-regulated transcriptional program using the P493-6 tetracycline-repressible MYC model. We demonstrate that both Myc-induced mRNAs and lncRNAs are significantly enriched for Myc binding sites. In contrast to Mycrepressed mRNAs, Myc-repressed lncRNAs are significantly enriched for Myc binding sites. Subcellular localization analysis revealed that compared to mRNAs, lncRNAs more often have a specific subcellular localization with a markedly higher percentage of nuclear enrichment within the Myc-repressed lncRNA set. Parallel analysis of differentially expressed lncRNAs and mRNAs identified 105 juxtaposed lncRNA-mRNA pairs, indicative for regulation in cis. To support the potential relevance of the Mycregulated lncRNAs in cellular transformation, we analyzed their expression in primary Myc-high and Myc-low B-cell lymphomas. In total, 54% of the lncRNAs differentially expressed between the lymphoma subsets were identified as Myc-regulated in P493-6 cells. This study is the first to show that lncRNAs are an important factor within the Myc-regulated transcriptional program and indicates a marked difference between Myc-repressed lncRNAs and mRNAs.
Introduction
Myc is frequently overexpressed both in solid tumors and B-cell lymphoma. Overexpression of Myc has significant effects on cell growth and proliferation, causes a general de-differentiation, and induces malignant transformation 1 . Myc targets a large number of protein-coding genes as well as microRNAs, of which several have been shown to contribute to the oncogenic effects of Myc 2 . To what extent Myc regulates transcription of long noncoding RNAs (lncRNAs) is a largely unexplored area of research.
LncRNAs are defined as RNA transcripts of >200 nucleotides in length that lack protein coding potential. Classification of lncRNAs is mainly based on their location and orientation with respect to protein coding genes, e.g., intronic, intergenic, or antisense. Many studies have described crucial roles for lncRNAs in a multitude of cellular processes 3, 4 . In these processes, lncRNAs can influence protein coding genes in multiple ways, e.g., by functioning as protein scaffolds 5, 6 , interacting with epigenetic complexes 7, 8 , regulating transcription in cis or trans [8] [9] [10] , or sequestering microRNAs 11 , 12 . In contrast, lncRNA loci have been shown to be regulated by the same epigenetic and transcriptional mechanisms as protein coding loci [13] [14] [15] [16] . Together, this suggests a complex regulatory network.
Deregulated lncRNA expression patterns have been implicated in cancer cell biology and multiple lncRNAs functioning as oncogenes and tumor repressor genes have been identified (reviewed in 17 ). The altered lncRNA expression patterns observed in cancer can be caused by various mechanisms, including DNA amplification, chromosomal translocations, chromatin modifications, and altered transcription factor activity such as that of Myc.
To broaden our understanding of Myc biology, we identified Myc-regulated lncRNAs in an in vitro B-cell lymphoma model and primary cases of B-cell lymphoma. We found that Myc strongly influences the lncRNA expression profile of the in vitro model and also of primary B-cell lymphoma samples. In addition, we studied several of the characteristics of the Myc-regulated lncRNAs including the presence of Myc binding sites, subcellular localization, and putative co-regulation of adjacent protein coding genes.
Cell Cultures (DSMZ, Braunschweig, Germany) (DG75). P493-6 B cells were a kind gift of Prof. D. Eick (Helmholtz Center, Munich, Germany). Cell lines were cultured at 37°C under an atmosphere containing 5% CO2 in RPMI-1640 medium supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM ultraglutamine, and 20% ST486 or 10% P493-6 and DG75 fetal calf serum (Cambrex Biosciences, Walkersville, MD, USA). For repression of Myc in P493-6, 0.1 µg/ml of tetracycline hydrochloride (University Medical Center Groningen [UMCG] Pharmacy, Groningen, The Netherlands) was added to the culture medium for 72 hours. For Myc re-induction, the cells were spun down (200 g, 5 minutes) and resuspended in fresh, tetracycline-free, complete medium for the indicated time.
Patient material
Frozen tumor samples of 13 BL and 9 CLL patients were collected from the Academisch Medisch Centrum Amsterdam and UMCG tissue banks. Each individual diagnosis was reviewed by an experienced hematopathologist according to the World Health Organization classification 18 . All BL cases carry a Myc translocation and are Epstein-Barr virus negative, CD20+, CD10+ and BCL2−. All CLL cases are lymph node derived, CD20+, CD5+ and cyclin D1− and have variable zeta-chain-associated protein kinase 70 (ZAP-70) expression. The procedures were performed according to the guidelines of the medical ethics board of the UMCG.
RNA isolation from cell lines, tissue samples, and nuclear and cytoplasmic fractions
For the RNA isolation from patient material, 10 to 20 10 μm sections were cut for each tumor sample (depending on the size of the tissue block). Tissue samples and cell lines were subjected to standard Trizol RNA isolation (Life Technologies, Carlsbad, CA, USA). RNA concentration was measured with a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), RNA integrity was assessed by 1% agarose electrophoresis. Nuclear and cytoplasmic fractions were separated from P493-6 MycOFF cells by adding 200 µL lysis buffer (140 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl pH8.0, 1 mM DTT, 0.5% Nonidet P-40) to pellets of ∼8 million cells, followed by 5 minutes incubation on ice and centrifugation for 3 minutes at 4°C and 100 g 19, 20 . The supernatant was collected as the cytoplasmic fraction. The pellet containing the nuclei was washed twice with lysis buffer. Qiazol (1 ml; Qiagen, Germantown, MD, USA) was added to the ∼200 µL cytoplasmic fraction, to the nuclear pellet, and to the total cell pellet. RNA was isolated using Phase Lock Gel Heavy (5 Prime, Hilden, Germany) and the RNeasy mini kit (Qiagen) according to the manufacturer's instructions.
Quantitative RT-PCR
cDNA was synthesized using random primers, dNTP mix, and the Superscript II Reverse Transcriptase Kit (Life Technologies Europe BV, Bleiswijk, The Netherlands) according to the manufacturer's instructions. An input of 500 ng RNA was used per sample in a total reaction volume of 20 µL. For detection of Myc, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), transcription factor A, mitochondrial (TFAM) and phosphoglycerate kinase 1 (PGK1) transcripts, TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA) were used according to the manufacturer's instructions. All other transcripts were assessed using SYBR Green mix (Applied Biosystems) in a quantitative PCR reaction volume of 10 µL with 300 nM primers. Triplicate quantitative PCR reactions were performed with 1 ng of cDNA on a LightCycler 480 system (Roche, Penzberg, Germany). Primer sequences and gene expression assays used in this study are listed in TABLE S1.
Western blot analysis
Cell lysates were prepared, separated on polyacrylamide gels, and transferred onto nitrocellulose membranes using standard protocols. All antibodies were diluted in 5% milk in Tris-buffered saline + Tween-20. Myc protein levels were determined by Western blot analysis using anti-c-Myc (rabbit mAb, N-term; 1:5000; Epitomics, Burlingame, CA, USA) and anti-β-actin (mouse mAb; 1:5000; Abcam Inc, Cambridge, MA, USA) as an internal loading control. As secondary antibodies, polyclonal horseradish peroxidaseconjugated goat anti-rabbit Ig (1:2000) and rabbit anti-mouse Ig (1:1000; both from Dako, Glostrup, Denmark) were used. For detection, the membranes were incubated with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA) according to the manufacturer's instructions. ChemiDoc MP scanner and Image Lab 4.0.1 Software (both from Bio-Rad, Veenendaal, The Netherlands) were used for visualization and quantification of protein bands, respectively.
Fluorescence-activated cell sorting analysis
Cell cycle distributions of P493-6 cells were analyzed using propidium iodide staining. In brief, cells were washed 3 times with PBS supplemented with 0.1% bovine serum albumin. Hypotonic propidium iodide staining solution (0.1% sodium citrate, 0.3% Triton X-100, 0.01% propidium iodide, 0.002% ribonuclease A in demineralized water) was added to the cell pellet, resuspended, and left on ice for ∼15 minutes before measurement with fluorescence-activated cell sorting (FACS) Calibur Flow Cytometer and Cell Quest software (BD Biosciences, San Jose, CA, USA). Forward scatter of live cells in complete medium were measured to determine cell size. Data were analyzed by FlowJo Flow Cytometry Analysis Software, v7.6 (Tree Star, Ashland, OR, USA).
Microarray study
LncRNA expression was investigated using a custom-designed microarray that contained 31,456 lncRNA and 27,186 mRNA probes. A total of 28,533 of the lncRNA probes were custom designed using eArray software (Agilent Technologies, Santa Clara, CA, USA) covering 97.3% of a published catalog of lncRNAs (8195 lncRNA loci, 2305 transcripts of uncertain coding potential loci, and 9 additional known lncRNA loci) 21 with an average of 3 probes per locus. The remainder of the lncRNA probes as well as all mRNA probes were derived from AMADID no. 028004 (Agilent Technologies). All of the following procedures were done according to the manufacturer's instructions. 50 to 100ng total RNA was spiked with the RNA Spike-in kit and labeled using the LowInput QuickAmp Labeling kit and the Cyanine 3 CTP Dye Pack (all Agilent Technologies). For the subcellular enrichment experiments, the dual-color LowInput QuickAmp Labeling Kit with cyanine 3 and 5 CTP Dye Packs were used. The total fraction was labeled with cyanine 3 and the nuclear and cytoplasmic fraction with cyanine 5. After labeling, cRNA samples were purified using the RNeasy Mini Kit (Qiagen), quantified on a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA) and hybridized on the custom array using the Gene Expression Hybridization Kit (Agilent Technologies). Arrays were scanned with the Agilent DNA Microarray Scanner and analyzed with Agilent Feature Extraction software v10.7.3.1. Resulting raw data were analyzed with GeneSpring GX 12.5 software (Agilent Technologies) using quantile normalization without baseline transformation. Probes used for further analyses were flagged as present by the feature extracting software in at least 1 of the 4 conditions (or 1 in 2 conditions for the BL and CLL samples) as well as consistently expressed in the 10th to 100th percentile. Using these conditions, a total of 15,355 mRNA and 9,559 lncRNA probes were consistently expressed above background in P493-6 and 13,163 mRNA and 6,517 lncRNA probes in BL and CLL samples. Statistical significant changes in expression upon Myc induction in P493-6 cells were determined by 1-way ANOVA using Benjamini-Hochberg multiple testing correction and Tukey's honestly significant difference post hoc test. Of these, all probes with a ≥2-fold change in expression were selected for the final list. Significant expression changes in BL vs. CLL were determined by moderated Student's t test, Benjamini-Hochberg multiple testing correction, and a ≥2-fold change in expression. Heat maps were generated with Genesis software v1.7.6 22 (Institute for Genomics and Bioinformatics Graz, Graz, Austria) and Pearson correlation as the distance metric. Array data used for this publication have been deposited in the Gene Expression Omnibus (GSE59480).
Gene set enrichment analysis and gene ontology analysis
Gene set enrichment analysis (GSEA) was performed using the Molecular Signatures Database (http://www.broad.mit.edu/gsea) 23 . Gene ontology (GO) analysis was performed using the DAVID ease Gene Functional Classification Tool 24, 25 . Myc-regulated mRNAs differentially expressed in P493-6 cells in the MycON or MycOFF state were assessed for functional gene cluster enrichment on the background of all genes expressed.
Myc binding site analysis
For the P493-6 Myc chromatin immunoprecipitation (ChIP) analysis, raw data were retrieved 26 for the 24 h MycON time point, aligned to the genome using Bowtie 2 27 , and analyzed using MACS software v1.4.2 with default settings 28 . This resulted in the identification of 2398 binding sites. This data set and a second publically available data set 29 were used to determine the distances between the center of the Myc binding sites and the location of the nearest differentially expressed mRNA or lncRNA probes. The percentage of Myc-induced or -repressed mRNA and lncRNA transcripts with a Myc binding site in close proximity (5, 10, or 20kb) was calculated. The control group comprised the percentage of Myc binding sites within 5, 10, or 20kb of all mRNA and lncRNA probes present on the array. Significant enrichment of Myc binding sites compared to the control was calculated by the chi-square test.
Myc inhibition using short hairpin RNAs in BL cell lines
Short hairpin RNAs (shRNAs) targeting MYC were cloned in the pGreenpuro lentivector (SBI, Mountain View, CA, USA) using 5′ BamHI and 3′ EcoRI sites. Scrambled control vector was purchased (SBI). Virus was generated with a third-generation lentiviral system in 293T cells using CaPO4 transfection. Virus was collected 2 days after transfection, filtered, and directly used or stored at −80°C. ST486 and DG75 cells were infected overnight, washed, and cultured. Four days after infection, the infection percentage was determined by FACS, and cells were collected for Western blot analysis and quantitative RT-PCR (qRT-PCR) 8 days after infection. Depending on the infection percentage, cells were collected without sorting (ST486, all samples >90% green fluorescent protein [GFP] positive) or GFP sorted (DG75, all samples >98% GFP positive). For each shRNA infection, 3 biologic replicates were generated and used for the lncRNA quantification by qRT-PCR (for ST486 shRNA2, only 2 biologic replicates were available). ShRNA sequences used are listed in TABLE S1.
Results

Identification of Myc-regulated lncRNAs
To investigate the effects of Myc on lncRNA expression, we used the widely applied P493-6 B cell line that carries a conditional, tetracycline-repressible MYC allele 30 . Tetracycline treatment (72 h) strongly decreased MYC mRNA and Myc protein levels, which returned to baseline within 4 and 6 hours after tetracycline removal, respectively (FIGURE 1A, F). Consistent with previous findings 30 , phenotypic changes upon inhibition of Myc included cell cycle arrest in G1 phase as well as a decrease in cell size and protein and RNA content per cell (FIGURE 1B-E). On the basis of the expression pattern of several known Myc-regulated mRNAs 31 , we selected 2 independent biologic replicates at the 4 and 24 hours time points after Myc induction and the steady-state MycOFF and MycON samples for lncRNA profiling (FIGURE 1F). Expression profiling was performed using a custom designed microarray that covers >10,000 intergenic lncRNAs 21 , ∼1,300 known lncRNAs, and all known protein coding genes. In concordance with the literature 32 , we observed a lower median expression level of lncRNAs compared to that of mRNAs (data not shown). We identified 6,555 mRNA and 2,014 lncRNA probes (1,244 lncRNA loci) with a significant differential expression between MycOFF and any of the 3 MycON time points (1-way ANOVA, false discovery rate [FDR] <0.05, fold change ≥2). GSEA and GO analysis of the Myc-regulated mRNAs revealed a significant enrichment of a previously identified Myc-responsive protein-coding gene set 33 and Myc-related gene ontologies 1 (FIGURE S1A; data not shown). This confirms that our samples indeed had the expected Myc-dependent gene expression profile. Unsupervised hierarchical clustering of the 2,014 differentially expressed lncRNA probes (47% Myc-induced and 53% Mycrepressed) revealed a pairwise clustering of MycOFF with Myc at 4 hours and of Myc at 24 hours with MycON samples (FIGURE 2A ). An early Myc response (4 hours) was observed for 30% of the lncRNA probes, whereas 56% showed a Myc-induced change in expression within 24 hours. Similar Myc response patterns were observed for mRNAs (FIGURE 2B). As a validation, we performed qRT-PCR and confirmed the Myc-induced up-regulation for 10 out of 10 successfully designed primer sets (FIGURE S1B). These results demonstrate that lncRNAs are an important component of the Myc-regulated transcriptional program.
Myc enhances lncRNA levels rather than causing de novo induction
Two studies argued that in general Myc acts as an amplifier of already expressed protein-coding genes rather than inducing de novo transcription 26, 34 . In line with these A B C findings, we observed that most (94%) of the Myc-induced protein-coding genes were already expressed in the MycOFF state, albeit at lower levels. A similar pattern was observed for Myc-induced lncRNAs, with 92% of the Myc-induced transcripts already being expressed in the MycOFF samples. The few putative de novo-induced lncRNAs and mRNAs showed expression levels that were close to the detection limit of the array in the MycON samples. These data demonstrate that in general, Myc-induced mRNAs and lncRNAs are already expressed when Myc levels are low.
Myc-regulated lncRNA loci are enriched for Myc binding sites
To confirm a direct Myc regulation of the differentially expressed lncRNAs and mRNAs, we assessed the presence of Myc binding sites using 2 previously generated Myc ChIP data sets 26, 29 . The distances between the Myc binding sites and the differentially expressed mRNAs and lncRNAs at the different time points were determined. As a control, the distances between the Myc binding sites and all lncRNAs or mRNAs on the array were calculated. Myc-induced mRNA transcripts showed consistent, highly significant enrichment for binding sites compared to control. In contrast, Myc-repressed mRNAs did not show any enrichment for Myc binding sites identified in P493-6 (FIGURE 2C) or only a minor enrichment for binding sites identified in BL cell lines (data not shown). For Myc-induced lncRNAs, a significant enrichment of Myc binding sites similar to that of Myc-induced mRNAs was observed. Interestingly, the Myc-repressed lncRNA set also showed a significant enrichment for Myc binding sites, especially in the 4 and 24 hours samples. Thus, Myc-induced lncRNAs and mRNAs as well as early Mycrepressed lncRNAs are enriched for Myc binding sites, whereas Myc-repressed mRNAs are not.
LncRNAs more often have a specific subcellular localization
The subcellular localization of lncRNAs may give a first indication of their putative function. For instance, a nuclear localization has been reported for myocardial infarction associated transcript, involved in splicing, and for ANRIL and X-inactive specific transcript, involved in epigenetic transcriptional control 35 . To study the subcellular localization of Myc-regulated lncRNAs, we analyzed cytoplasmic and nuclear fractions of P493-6 cells. As a control for the isolation of the fractions, 6 transcripts with a known subcellular localization were analyzed and showed the expected enrichment and depletion in the respective fractions. (FIGURE 3A AND B) . LncRNAs significantly more often showed a specific subcellular localization compared to mRNAs (37% vs. 13%, FIGURE 3C ).
Of the lncRNAs with a specific subcellular localization, >60% showed enrichment in the nuclear fraction. Within the Myc-regulated lncRNAs, a strong prevalence for nuclear enrichment could be observed for Myc-repressed lncRNAs. For Myc-regulated mRNAs, a similar trend was observed, although less pronounced (data not shown). Significance was calculated by chi-square test.
Expression correlation of lncRNAs and mRNAs in close vicinity
Because multiple lncRNAs have been shown to positively or negatively influence gene expression of neighboring genes in cis (reviewed in 36 ), we explored putative lncRNAmediated cis regulation. We defined putative cis regulation as juxtaposed pairs of Myc-regulated lncRNAs and Myc-regulated mRNAs within a probe-to-probe distance of 20kb. Using these settings, we identified 105 cis-regulatory lncRNA candidates (TABLE S2) , with a sense orientation for 38, a tail to tail for 36, a head to head for 18, an antisense for 12, and an intronic localization for one lncRNA-mRNA pair. The direction of expression was concordantly up-and downregulated for 41 and 32 pairs, respectively. For 32 (30%) of the 105 pairs, we observed an inverse correlation. Inverse correlations were more often observed within the lncRNA sets with antisense and tail-to-tail orientations (respectively, 42% and 36%) and less within the sets with sense and headto-head orientations (respectively, 23% and 22%). FIGURE 4A ). Similar to the lncRNAs differentially expressed in the P493-6 model, we also observed significant enrichment of Myc binding sites for both lncRNAs with increased and decreased expression levels in BL compared to CLL (FIGURE 4B) . For mRNAs, a significant Myc binding site enrichment was observed for the genes with high expression levels in BL compared to CLL. For mRNAs with low levels in BL, a less pronounced Myc binding site enrichment was observed, in line with the P493-6 results. To confirm a Myc-dependent regulation in BL, we analyzed the expression of the validated Myc-induced lncRNAs in BL cell lines ST486 and DG75 treated with 2 different shRNA constructs against Myc. This revealed for 5 out of 9 (ST486) and 7 out of 7 (DG75) expressed lncRNAs the expected pattern of decreased levels upon Myc knockdown (FIG. S1C TO F) . 
Myc regulated lncRNAs in primary B-cell lymphoma
Discussion
This study shows that lncRNAs, next to mRNAs and microRNAs, are an important component of the Myc-regulated gene expression network. In total, we identified 1,244 lncRNA loci that were regulated by Myc in the P493-6 model. So far, only 3 lncRNAs have been described to be induced by Myc, i.e., CCAT1-L, H19, and HOTAIR 37, 38 [reviewed in 39 ]. CCAT1-L and HOTAIR are not expressed in the cell types investigated in this study. H19 is not expressed in P493-6 cells, but it shows a higher expression in BL cases compared CLL cases, in accordance with an up regulation by Myc. Furthermore, our data are in line with a recent study showing that a substantial part of the deregulated lncRNA expression in murine dicer knockout embryonic stem cells can be attributed to deregulated Myc expression 40 . Next to lncRNAs that are regulated by c-Myc (which we referred to throughout as Myc), a few lncRNAs have also been described to be controlled by the structurally related n-Myc protein. Three transcribed ultraconserved regions (T-UCRs) were induced, and long intergenic noncoding (linc) 00467 was shown to be repressed by n-Myc 41, 42 . No probes were available on our array for the T-UCRs.
Linc00467 was approximately 3-fold down-regulated in P493-6 upon Myc induction but showed no clear difference in expression between BL and CLL cases. Thus, this is the first study to report a comprehensive overview of the lncRNAs regulated by Myc.
One of the remarkable findings in this study is the enrichment of Myc binding sites for Myc-repressed lncRNAs, indicating direct regulation by Myc. The lack of binding site enrichment for Myc-repressed mRNAs suggests that these transcripts are in general not directly targeted by Myc. To what extent Myc can repress the expression of mRNAs is currently under debate. Two studies proposed that Myc acts as an amplifier of practically all expressed genes without obvious specificity 26, 34 . However, 2 recent studies argued for a model in which Myc can directly induce and repress specific genes 43, 44 . The globally increased RNA production was proposed to be an indirect effect due to the regulation of genes involved in RNA synthesis. In these 2 recent studies, the investigators did not discriminate between protein-coding and noncoding genes, which possibly explains why no noticeable difference in Myc binding was observed between induced and repressed target genes. Another factor that may explain this dissimilarity is the differences in the amount of Myc binding sites defined during Myc overexpression in the recent studies 43, 44 (30,000 and 45,645 sites) compared to the 2 data sets 26, 29 we used (2,398 and 7,054 sites). Because Myc first occupies high-affinity target genes before binding to loweraffinity targets 1, 44 , it is likely that our smaller sets are more enriched for high-affinity genes. Possible enrichment of Myc-repressed lncRNAs and/or depletion of Mycrepressed mRNAs within the high-affinity Myc target gene set compared to the lowaffinity target gene set could explain the observed differences in direct Myc binding between Myc-repressed mRNAs and lncRNAs. Thus, although the reason for the marked difference between Myc-repressed mRNAs and lncRNAs in our study is yet unclear, it suggests a crucial role for both Myc-induced and Myc-repressed lncRNAs.
Expression analysis of nuclear, cytoplasmic, and total fractions revealed that lncRNAs, compared to mRNAs, more often have a specific subcellular localization. In line with other studies 21, 32, 45 , a high number of lncRNAs were enriched in the nucleus. It has been reported that nuclear lncRNAs, similar to nuclear mRNAs, are significantly less stable than cytoplasmic transcripts or transcripts without specific localization 45 . Moreover, stable mRNAs are frequently involved in housekeeping or metabolic functions, while instable mRNA species are involved in gene regulatory functions that require a fast response to external or internal stimuli and thus a rapid turnover 45, 46 . The frequent nuclear localization, combined with the observed Myc binding site enrichment of Mycrepressed lncRNAs, suggests that Myc directly down-regulates lncRNAs that regulate dynamic nuclear processes.
The parallel analysis of lncRNA and mRNA expression in P493-6 upon Myc induction identified >100 differentially expressed mRNAs that are directly adjacent to differentially expressed lncRNAs. Modulation of lncRNA expression at the endogenous locus in order to determine effects on the neighboring gene or genes should indicate whether these lncRNAs can indeed regulate gene expression in cis. The fact that we observed an inverse correlation in expression upon Myc induction between the lncRNA and mRNA for 30% of the pairs indicates that at least for this group, the changes in expression are not simply due to an open or closed local chromatin structure and supports putative regulation in cis.
To support the relevance of the identified lncRNAs in P493-6, we studied lncRNA expression in primary lymphomas characterized by high and low Myc levels. More than half of the lncRNAs differentially expressed in lymphoma were also identified as Mycregulated in P493-6, indicating the potential relevance of these lncRNAs. We selected CLL as an example of a Myc-low lymphoma; although not tested, we expect similar results when compared to other Myc-low lymphoma subtypes, such as follicular or mantle cell lymphoma. The relevance of Myc in establishing this Myc-dependent profile in BL was further confirmed by analysis of lncRNA expression levels on shRNA-based inhibition of Myc in BL cell lines. At present, the diagnostic utility of the identified lncRNAs is uncertain. However, it might be of diagnostic value in diffuse large B-cell lymphoma. Genes that are Myc-responsive have been used to determine the Myc activity, and this was shown to be an independent negative prognostic factor in diffuse large B-cell lymphoma 47 .
It is well known that inhibition of Myc in BL cell lines strongly impairs their growth 48 (data not shown). Because Myc regulates many mRNAs and microRNAs, it is intriguing that reversing the effect of Myc on the expression of a single Myc-regulated gene can have a strong negative effect on cell growth 49, 50 . This strongly suggests that Myc has to orchestrate a wide range of genes in specific directions to be able to exert its effects on cell growth. Known functions of Myc relevant in oncogenesis include progression of cell cycle, blocking differentiation, and promoting transformation 2 . It may be expected that several of the Myc-regulated lncRNAs identified in this study are essential in the above-mentioned processes.
In > 35 ). The shown lncRNA quantification is an average of 3 independent biological replicates (for shRNA2 infected ST486 only 2 replicates). 18S was used for normalization and 2 -ΔCt was calculated and multiplied by 10 6 . For each independent biological replicate the scrambled control (SCR) was set to 1. Significance was calculated by t-test. 
